EULAR recommendations for the management of primary small and medium vessel vasculitis
Authors:
Top Cited Papers
- 1 March 2009
- journal article
- review article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 68 (3) , 310-317
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Limited versus severe Wegener's granulomatosis: Baseline data on patients in the Wegener's granulomatosis etanercept trialArthritis & Rheumatism, 2003
- High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low‐dose methotrexateArthritis Care & Research, 2002
- Standardized Neurologic Evaluations of 128 Patients With Wegener GranulomatosisArchives of Neurology, 2001
- Etanercept combined with conventional treatment in Wegener's granulomatosis: A six-month open-label trial to evaluate safetyArthritis & Rheumatism, 2001
- Epidemiology of Wegener's granulomatosis in Northern NorwayArthritis & Rheumatism, 2000
- Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective studyArthritis & Rheumatism, 2000
- Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis: Long-term renal outcome in patients with glomerulonephritisArthritis & Rheumatism, 2000
- Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegener's granulomatosis undergoing immunosuppressive therapyArthritis & Rheumatism, 2000
- An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patientsArthritis & Rheumatism, 2000
- Cyclophosphamide‐induced bladder toxicity in wegener's granulomatosisArthritis & Rheumatism, 1988